Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

ELTP

Elite Pharmaceuticals, Inc.

USD

Set alert

Price alert · ELTP

All alert types
0.23 USD 0.00 0.00%
As of Oct 30, 2026
0.22 Day range 0.233
0.22 52-week range 0.68
YTD
-53.06%
1 year
-62.30%
Open
0.23
Prev close
0.23
Mkt cap
247.74M
Vol
503.23K
Avg vol
817.00K
EPS
0.04
P/E
5.75
More statistics
Low
0.22
High
0.233

5D chart

Chart tools
Interval
1m5m15m30m
ELTP five-day price chart0.230.230.240.250.26Oct 21Oct 22Oct 23Oct 26Oct 27

Financial health

Altman Z-Score

6.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A+4 / 5 overall

  • DCF 4
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 4
  • P/B 2

Valuation

P/E 8.7×
FY 2017: 5.0×FY 2018: -21.7×FY 2019: -8.8×FY 2020: -25.9×FY 2021: 11.1×FY 2022: 4.0×FY 2023: 0.0×FY 2024: 7.7×FY 2025: -109×FY 2026: 8.7×
FY 2017 5y median 4.0× FY 2026
P/S 2.6×
FY 2017: 13.1×FY 2018: 10.7×FY 2019: 10.8×FY 2020: 3.2×FY 2021: 2.2×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 2.7×FY 2025: 5.5×FY 2026: 2.6×
FY 2017 5y median 2.6× FY 2026
P/B 3.9×
FY 2017: 4.9×FY 2018: 4.3×FY 2019: 7.1×FY 2020: 5.5×FY 2021: 3.5×FY 2022: 1.4×FY 2023: 1.0×FY 2024: 2.7×FY 2025: 8.7×FY 2026: 3.9×
FY 2017 5y median 2.7× FY 2026
P/FCF 0.0×
FY 2017: -14.0×FY 2018: -15.7×FY 2019: -12.0×FY 2020: -31.9×FY 2021: 19.8×FY 2022: 5.9×FY 2023: -12.2×FY 2024: -38.0×FY 2025: 94.3×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
EV/EBITDA -566×
FY 2017: 40.7×FY 2018: -22.6×FY 2019: -10.0×FY 2020: -164×FY 2021: 15.4×FY 2022: 4.5×FY 2023: 3.9×FY 2024: 63.4×FY 2025: 163×FY 2026: -566×
FY 2017 5y median 4.5× FY 2026
EV/Sales -198×
FY 2017: 12.2×FY 2018: 10.2×FY 2019: 11.0×FY 2020: 3.4×FY 2021: 2.2×FY 2022: 0.9×FY 2023: 0.7×FY 2024: 2.8×FY 2025: 5.5×FY 2026: -198×
FY 2017 5y median 0.9× FY 2026
FCF Yield 5870.0%
FY 2017: -7.1%FY 2018: -6.4%FY 2019: -8.4%FY 2020: -3.1%FY 2021: 5.1%FY 2022: 17.0%FY 2023: -8.2%FY 2024: -2.6%FY 2025: 1.1%FY 2026: 5870.0%
FY 2017 5y median 1.1% FY 2026

Profitability

Gross Margin 49.4%
FY 2017: 38.8%FY 2018: 52.9%FY 2019: 37.9%FY 2020: 44.3%FY 2021: 46.8%FY 2022: 45.9%FY 2023: 48.6%FY 2024: 46.5%FY 2025: 47.7%FY 2026: 49.4%
FY 2017 5y median 47.7% FY 2026
Operating Margin 33.6%
FY 2017: -76.3%FY 2018: -121.4%FY 2019: -121.0%FY 2020: -12.7%FY 2021: 8.3%FY 2022: 15.7%FY 2023: 5929.2%FY 2024: 19.1%FY 2025: 23.3%FY 2026: 33.6%
FY 2017 5y median 23.3% FY 2026
Net Margin 30.1%
FY 2017: 39.5%FY 2018: -49.2%FY 2019: -122.6%FY 2020: -12.5%FY 2021: 20.0%FY 2022: 27.6%FY 2023: 12.9%FY 2024: 35.5%FY 2025: -5.1%FY 2026: 30.1%
FY 2017 5y median 27.6% FY 2026
ROE 45.4%
FY 2017: 14.9%FY 2018: -19.9%FY 2019: -81.4%FY 2020: -21.0%FY 2021: 31.5%FY 2022: 35.3%FY 2023: 15.2%FY 2024: 34.9%FY 2025: -8.1%FY 2026: 45.4%
FY 2017 5y median 34.9% FY 2026
ROIC 32.3%
FY 2017: -23.4%FY 2018: -29.1%FY 2019: -48.3%FY 2020: -12.4%FY 2021: 10.0%FY 2022: 17.5%FY 2023: 6065.4%FY 2024: 14.3%FY 2025: 21.9%FY 2026: 32.3%
FY 2017 5y median 21.9% FY 2026
ROA 32.4%
FY 2017: 11.1%FY 2018: -11.9%FY 2019: -38.0%FY 2020: -9.0%FY 2021: 19.4%FY 2022: 25.3%FY 2023: 10.8%FY 2024: 24.0%FY 2025: -4.5%FY 2026: 32.4%
FY 2017 5y median 24.0% FY 2026

Growth (YoY)

Revenue 77.1%
FY 2017: -22.9%FY 2018: -22.6%FY 2019: 1.5%FY 2020: 137.8%FY 2021: 41.0%FY 2022: 27.1%FY 2023: 5.9%FY 2024: 65.8%FY 2025: 48.4%FY 2026: 77.1%
FY 2017 FY 2026
Operating Income 154.9%
FY 2017: 11.6%FY 2018: -23.0%FY 2019: -1.2%FY 2020: 75.0%FY 2021: 192.1%FY 2022: 140.9%FY 2023: 39837.4%FY 2024: -99.5%FY 2025: 81.7%FY 2026: 154.9%
FY 2017 FY 2026
EPS (diluted) 912.5%
FY 2017: -900.0%FY 2018: 54.0%FY 2019: -147.8%FY 2020: 76.3%FY 2021: 300.0%FY 2022: 37.0%FY 2023: 58683.8%FY 2024: -99.5%FY 2025: -120.3%FY 2026: 912.5%
FY 2017 FY 2026
Free Cash Flow 462778.1%
FY 2017: -90.7%FY 2018: 43.4%FY 2019: -34.0%FY 2020: 73.2%FY 2021: 256.6%FY 2022: 109.8%FY 2023: -139.9%FY 2024: -70.6%FY 2025: 220.5%FY 2026: 462778.1%
FY 2017 FY 2026

Financial Health

Current Ratio 6.4×
FY 2017: 5.5×FY 2018: 2.7×FY 2019: 1.3×FY 2020: 1.2×FY 2021: 2.1×FY 2022: 2.8×FY 2023: 2.7×FY 2024: 3.1×FY 2025: 4.9×FY 2026: 6.4×
FY 2017 5y median 3.1× FY 2026
Quick Ratio -1216×
FY 2017: 3.6×FY 2018: 1.7×FY 2019: 0.6×FY 2020: 0.7×FY 2021: 1.2×FY 2022: 1.8×FY 2023: 1.5×FY 2024: 2.1×FY 2025: 3.5×FY 2026: -1216×
FY 2017 5y median 1.8× FY 2026
Debt / Equity 0.1×
FY 2017: 0.1×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.4×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -573×
FY 2017: -2.7×FY 2018: 0.9×FY 2019: -0.2×FY 2020: -7.8×FY 2021: -0.2×FY 2022: -0.9×FY 2023: -0.6×FY 2024: 1.8×FY 2025: -0.1×FY 2026: -573×
FY 2017 5y median -0.6× FY 2026
Interest Coverage 126×
FY 2017: -30.9×FY 2018: -27.0×FY 2019: -24.8×FY 2020: -6.4×FY 2021: 8.1×FY 2022: 26.4×FY 2023: 1820×FY 2024: 18.3×FY 2025: 25.4×FY 2026: 126×
FY 2017 5y median 26.4× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-03-31